NVO vs PFE
Novo Nordisk A/S vs Pfizer Inc. — AI-powered side-by-side comparison
| Metric | NVO | PFE |
|---|---|---|
| AI Score | 53 | 50 |
| Price | $48.95 | $24.25 |
| P/E Ratio | 11.67× | 18.42× |
| ROE | 66.4% | 8.4% |
| Revenue Growth YoY | 8.1% | 1.4% |
| Gross Margin | 81.8% | 74.8% |
| Debt / Equity | 0.67× | 0.75× |
| Dividend Yield | 3.6% | 7.2% |
| RSI (14) | 61.1 | 40.5 |
| Beta | 1.8569 | 0.2845 |
| Expected Upside | +27.5% | +8.4% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
NVO Full Analysis
PFE Full Analysis